{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:20:00Z","timestamp":1784204400493,"version":"3.55.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Independent Medical Alliance"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The National Academies of Science, Engineering, and Medicine (NASEM) has defined Long COVID as \u201can infection-associated chronic condition (IACC) that occurs after SARS-CoV-2 infection and is present for at least 3\u202fmonths as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems.\u201d This definition puts the experience of the patient primary, where the decisive factor for diagnosis is a persistent health problem after COVID-19 infection. Ongoing work aims to characterize the biological signature of both Long COVID and Post-Acute COVID-19 Vaccination Syndrome (PACVS), clinicians and researchers are faced with heterogeneous diseases that are not easily captured by a single biomarker. Candidate biomarkers establish spike protein persistence, either through detection of full length spike, the S1 subunit of spike protein, or anti-spike protein antibody positivity. Additionally, to rule out viral reservoirs or active infection as an explanation, anti-nucleocapsid antibody, a hallmark of COVID-19 infection not present in the vaccine, should be negative. Other candidate biomarkers include detection of vaccine sequence mRNA, or sequence differentiation of viral from vaccinal spike through mass spectrometry. Despite candidate biomarkers, medicine is far from a definitive diagnostic test. Lack of diagnosis has created negative experiences for patients and strengthened vaccine hesitancy. An open acknowledgement of vaccine risks is vital to restoring trust in science and medicine and ensuring those injured have access to the care they need.<\/jats:p>","DOI":"10.3389\/fmed.2025.1688170","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:28:25Z","timestamp":1764311305000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Restoring trust in vaccination: listening to patients and acknowledging Post-Acute COVID Vaccine Syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Matthew","family":"Halma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.17226\/27768","volume-title":"A Long COVID definition: A chronic, systemic disease state with profound consequences","author":"Fineberg","year":"2024"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/covid5080135","article-title":"A case definition of a new disease: a review of the US working definition (USG) and 2024 NASEM definition for Long COVID","volume":"5","author":"Perego","year":"2025","journal-title":"COVID"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e14037","DOI":"10.1111\/hex.14037","article-title":"Barriers to healthcare access and experiences of stigma: findings from a coproduced long covid case-finding study","volume":"27","author":"Clutterbuck","year":"2024","journal-title":"Health Expect"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e70070","DOI":"10.1002\/rmv.70070","article-title":"Post-COVID-19 vaccination (or long vax) syndrome: putative manifestation, pathophysiology, and therapeutic options","volume":"35","author":"Shin Jie","year":"2025","journal-title":"Rev Med Virol"},{"key":"ref5","first-page":"103","article-title":"Close to home: a history of Yale and Lyme disease","volume":"84","author":"Elbaum-Garfinkle","year":"2011","journal-title":"Yale J Biol Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease-a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJM198303313081302","article-title":"Spirochetes isolated from the blood of two patients with Lyme disease","volume":"308","author":"Benach","year":"1983","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/infdis\/149.5.789","article-title":"Antibody response in Lyme disease: evaluation of diagnostic tests","volume":"149","author":"Craft","year":"1984","journal-title":"J Infect Dis"},{"key":"ref9","first-page":"412","article-title":"Examination of Koch\u2019s postulates for Borrelia burgdorferi as the causative agent of limb\/joint dysfunction in dogs with borreliosis","volume-title":"J Am Vet Med Assoc","author":"Wasmoen","year":"1992"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.healthpol.2011.05.007","article-title":"Healthcare access and burden of care for patients with Lyme disease: a large United States survey","volume":"102","author":"Johnson","year":"2011","journal-title":"Health Policy"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"112189","DOI":"10.1016\/j.celrep.2023.112189","article-title":"SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice","volume":"42","author":"Fontes-Dantas","year":"2023","journal-title":"Cell Rep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"eado2104","DOI":"10.1126\/scitranslmed.ado2104","article-title":"Animal models of Long Covid: a hit-and-run disease","volume":"16","author":"Sch\u00e4fer","year":"2024","journal-title":"Sci Transl Med"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e43478","article-title":"Breaking the silence: recognizing post-vaccination syndrome","volume-title":"Heliyon","author":"Halma","year":"2025"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e28568","DOI":"10.1002\/jmv.28568","article-title":"Persistent circulation of soluble and extracellular vesicle-linked spike protein in individuals with postacute sequelae of COVID-19","volume":"95","author":"Craddock","year":"2023","journal-title":"J Med Virol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post\u2013COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/jev2.70001","article-title":"Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19","volume":"13","author":"De Miguel-Perez","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3390\/biomedicines12122852","article-title":"Autoantibodies targeting G-protein-coupled receptors and RAS-related molecules in post-acute COVID vaccination syndrome: a retrospective case series study","volume":"12","author":"Mantovani","year":"2024","journal-title":"Biomedicine"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e12117","DOI":"10.1002\/jev2.12117","article-title":"Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity","volume":"10","author":"Krishnamachary","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jinf.2022.06.030","article-title":"Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection","volume":"85","author":"Gao","year":"2022","journal-title":"J Infect"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/cells12050688","article-title":"Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID","volume":"12","author":"Theoharides","year":"2023","journal-title":"Cells"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"605908","DOI":"10.3389\/fphys.2020.605908","article-title":"SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress","volume":"11","author":"Chang","year":"2021","journal-title":"Front Physiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.3390\/v13112209","article-title":"SARS-CoV-2 spike protein S1-mediated endothelial injury and pro-inflammatory state is amplified by dihydrotestosterone and prevented by mineralocorticoid antagonism","volume":"13","author":"Kumar","year":"2021","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/microorganisms9102167","article-title":"Severity, pathogenicity and transmissibility of delta and lambda variants of SARS-CoV-2, toxicity of spike protein and possibilities for future prevention of COVID-19","volume":"9","author":"Moghaddar","year":"2021","journal-title":"Microorganisms"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s15010-021-01677-8","article-title":"SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies","volume":"49","author":"Almehdi","year":"2021","journal-title":"Infection"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1134\/S0006297921030032","article-title":"Free SARS-CoV-2 spike protein S1 particles May play a role in the pathogenesis of COVID-19 infection","volume":"86","author":"Letarov","year":"2021","journal-title":"Biochem Mosc"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"111223","DOI":"10.1016\/j.jocn.2025.111223","article-title":"Expression of SARS-CoV-2 spike protein in cerebral arteries: implications for hemorrhagic stroke post-mRNA vaccination","volume":"136","author":"Ota","year":"2025","journal-title":"J Clin Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.4317\/jced.60891","article-title":"Neurological complications following mRNA COVID-19 vaccination: Oral and lower limb paresthesia. A case discussion and literature review","volume":"15","author":"L\u00f3pez-Carriches","year":"2023","journal-title":"J Clin Exp Dent"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jdermsci.2025.09.007","article-title":"A case of metastatic breast carcinoma to the skin expressing SARS-CoV-2 spike protein possibly derived from mRNA vaccine","volume":"120","author":"Sano","year":"2025","journal-title":"J Dermatol Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2494934","DOI":"10.1080\/21645515.2025.2494934","article-title":"Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals","volume":"21","author":"Patterson","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3390\/vaccines12111281","article-title":"The immunologic downsides associated with the powerful translation of current COVID-19 vaccine mRNA can be overcome by mucosal vaccines","volume":"12","author":"Federico","year":"2024","journal-title":"Vaccine"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e17958","DOI":"10.1016\/j.heliyon.2023.e17958","article-title":"Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19","volume":"9","author":"Jang","year":"2023","journal-title":"Heliyon"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1016\/j.vaccine.2021.07.066","article-title":"Quantification of SARS-CoV-2 spike and nucleocapsid proteins using isotope dilution tandem mass spectrometry","volume":"39","author":"Pierce-Ruiz","year":"2021","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1016\/j.vaccine.2023.04.044","article-title":"Quantification of SARS-CoV-2 spike protein expression from mRNA vaccines using isotope dilution mass spectrometry","volume":"41","author":"Sutton","year":"2023","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/vaccines11051002","article-title":"The quantification of spike proteins in the inactivated SARS-CoV-2 vaccines of the prototype, Delta, and omicron variants by LC\u2013MS","volume":"11","author":"Xu","year":"2023","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1021\/acs.jproteome.0c00412","article-title":"Mass-spectrometric detection of SARS-CoV-2 virus in scrapings of the epithelium of the nasopharynx of infected patients via nucleocapsid N protein","volume":"19","author":"Nikolaev","year":"2020","journal-title":"J Proteome Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1021\/acs.jproteome.2c00325","article-title":"Evaluation of variant-specific peptides for detection of SARS-CoV-2 variants of concern","volume":"21","author":"Suddhapas","year":"2022","journal-title":"J Proteome Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1002\/mco2.167","article-title":"mRNA vaccines in the prevention and treatment of diseases","volume":"3","author":"Gu","year":"2022","journal-title":"MedComm"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3390\/molecules30071629","article-title":"Current analytical strategies for mRNA-based therapeutics","volume":"30","author":"Camperi","year":"2025","journal-title":"Molecules"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","article-title":"Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination","volume":"185","author":"R\u00f6ltgen","year":"2022","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biomedicines12010059","article-title":"Biodistribution of RNA vaccines and of their products: evidence from human and animal studies","volume":"12","author":"Pateev","year":"2023","journal-title":"Biomedicine"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"789427","DOI":"10.3389\/fcell.2021.789427","article-title":"The critical contribution of Pseudouridine to mRNA COVID-19 vaccines","volume":"9","author":"Morais","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2015.08.051","article-title":"N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice","volume":"217","author":"Andries","year":"2015","journal-title":"J Control Release"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.3390\/jcm13237291","article-title":"The WHO algorithm for causality assessment of adverse effects following immunization with genetic-based anti-COVID-19 vaccines: pitfalls and suggestions for improvement","volume":"13","author":"Bellavite","year":"2024","journal-title":"J Clin Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.12688\/f1000research.13694.2","article-title":"Revised world health organization (WHO)\u2018s causality assessment of adverse events following immunization\u2014a critique","volume":"7","author":"Puliyel","year":"2018","journal-title":"F1000Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.3390\/ijms231810881","article-title":"Understanding the pharmacology of COVID-19 mRNA vaccines: playing dice with the spike?","volume":"23","author":"Cosentino","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.3390\/biomedicines11082287","article-title":"\u2018Spikeopathy\u2019: COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA","volume":"11","author":"Parry","year":"2023","journal-title":"Biomedicine"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"100163","DOI":"10.1016\/j.endmts.2024.100163","article-title":"Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology","volume":"14","author":"Halma","year":"2024","journal-title":"Endocr Metab Sci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.46804\/2641-2225.1194","article-title":"Knowledge, attitudes, and practices of vaccine adverse event reporting among family medicine faculty and resident physicians","volume":"6","author":"Lewin","year":"2024","journal-title":"J Maine Med Cent"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"p2582","DOI":"10.1136\/bmj.p2582","article-title":"Is the US\u2019S vaccine adverse event reporting system broken?","volume":"383","author":"Block","year":"2023","journal-title":"BMJ"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/vaccines10071049","article-title":"Percentage of asymptomatic infections among SARS-CoV-2 omicron variant-positive individuals: a systematic review and Meta-analysis","volume":"10","author":"Shang","year":"2022","journal-title":"Vaccine"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e2140364","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"key":"ref55","volume-title":"Minimizing public susceptibility to misconceptions about the effects of vaccination: vaccine adverse event reporting system (VAERS)","author":"Jamieson","year":"2023"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj6981","article-title":"Antivaccine activists use a government database on side effects to scare the public","author":"Wadman","year":"2021","journal-title":"Science"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.3346\/jkms.2024.39.e220","article-title":"A causality assessment framework for COVID-19 vaccines and adverse events at the COVID-19 vaccine safety research center","volume":"39","author":"Kim","year":"2024","journal-title":"J Korean Med Sci"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/JRS-220043","article-title":"The coverage of medical injuries in company trial informed consent forms","volume":"34","author":"Healy","year":"2023","journal-title":"Int J Risk Saf Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1329878X241236984","article-title":"Labelling, shadow bans and community resistance: did Meta\u2019s strategy to suppress rather than remove COVID misinformation and conspiracy theory on Facebook slow the spread?","volume":"197","author":"Johns","year":"2025","journal-title":"Media Int Aust"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/08854300.2024.2309805","article-title":"The impact of censorship on COVID-19 policy formation in the United States","volume":"38","author":"Wallis","year":"2024","journal-title":"Soc Democr"},{"key":"ref61","first-page":"256","volume-title":"Worth a shot?: Secrets of the clinical trial participant who inspired a global movement\u2014Brianne Dressen\u2019s story","author":"Pover","year":"2024"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/biomed3020023","article-title":"Public health needs the public trust: a pandemic retrospective","volume":"3","author":"Halma","year":"2023","journal-title":"BioMed"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3390\/vaccines12121378","article-title":"The post-acute COVID-19-vaccination syndrome in the light of pharmacovigilance","volume":"12","author":"Platschek","year":"2024","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.amepre.2017.01.014","article-title":"Vaccine education of medical students: a Nationwide cross-sectional survey","volume":"53","author":"Kern\u00e9is","year":"2017","journal-title":"Am J Prev Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12889-024-17678-9","article-title":"Misinformation, knowledge and COVID-19 vaccine acceptance: a cross-sectional study among health care workers and the general population in Kampala, Uganda","volume":"24","author":"Atuheirwe","year":"2024","journal-title":"BMC Public Health"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"7990876","DOI":"10.1155\/av\/7990876","article-title":"The possible mechanistic basis of individual susceptibility to spike protein injury","volume":"2025","author":"Halma","year":"2025","journal-title":"Adv Virol"},{"key":"ref67","article-title":"The constitutional dimension of free speech under the Biden administration","volume-title":"DPCE Online","author":"Andreoli","year":"2024"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1688170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T06:28:29Z","timestamp":1764311309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1688170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":67,"alternative-id":["10.3389\/fmed.2025.1688170"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1688170","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"1688170"}}